Catalyst Wire Dossier

Diseases Search Methodology Pricing Log in Sign up free

Diseases · Lymphoma Non-hodgkin

Lymphoma Non-hodgkin

📧 Sign up to get email alerts when something new happens for Lymphoma Non-hodgkin.

Top drugs studied for this disease

Rituximab Mabion (1)
ASN002 (1)
TCRαβ+ depleted stem cell transplant (1)
Bellicum gene-modified donor T-cells (1)
CAR-T cell therapy targeting CD19 (fully-human anti-CD19 CAR) (1)
PBCAR20A (1)
Gene Modified Donor T-cells after TCR Alpha Beta Positive Depleted Stem Cell Transplant (1)
Bexxar/BEAM (1)
Rituxan/BEAM (1)
Mitoguazone dihydrochloride (1)

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

No documents found for this filter.

Catalyst Wire Dossier

FDA, ClinicalTrials.gov, and EMA — organized by disease, AI-summarized. Daily updates.

Catalyst Wire family

Dossier SEC FDA Frontier Briefing

Stay updated

Website

Daily FDA actions. One-time €1 verification charge; no recurring payment. Confirm by email, unsubscribe anytime.

Data: openFDA, ClinicalTrials.gov, EMA. Analysis by GPT-5-nano. Not medical advice. · Methodology · Privacy · Terms